Related Experiment Video

Updated: Aug 18, 2026

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons
09:11

Zika Virus Infectious Cell Culture System and the In Vitro Prophylactic Effect of Interferons

Published on: August 23, 2016

[Treatment of chronic hepatitis with interferon in children with kidney diseases]

Maria Szczepańska1, Anna Tobis, Barbara Schneiberg

  • 1Klinika Pediatrii, Nefrologii i Endokrynologii Dzieciecej Slaskiej Akademii Medycznej w Zabrzu.

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|April 30, 2005
PubMed

Insights

Interferon treatment for chronic hepatitis in children with prior kidney issues showed comparable efficacy to those without kidney disease. This treatment generally did not cause complications or increase relapse risk for conditions like glomerulonephritis.

Area of Science:

  • Pediatric Gastroenterology and Hepatology
  • Nephrology
  • Virology

Context:

  • Chronic hepatitis is a significant concern in pediatric populations.
  • Children with pre-existing nephrological conditions present unique challenges for hepatitis treatment.
  • Interferon (IFN) therapy is a standard treatment for chronic viral hepatitis.

Purpose:

  • To evaluate the efficacy and safety of interferon treatment for chronic hepatitis in children with a history of nephrological indications.
  • To compare treatment outcomes in this cohort with those of children without kidney disease.
  • To assess the risk of complications and disease relapse in children with glomerulonephritis receiving IFN therapy.

Summary:

  • This study examined 42 children (mean age 10.2 years) with chronic HBV, HCV, or mixed infections, many with prior glomerulonephritis or nephrotic syndrome.
  • Interferon alpha-2a, alpha-2b, or recombinant IFN-alpha was administered, with biochemical and virological markers monitored.
  • Treatment showed comparable efficacy to general pediatric populations, with few side effects and no increased risk of renal disease relapse.

Impact:

  • Interferon therapy appears safe and effective for children with chronic hepatitis who have a history of kidney disease.
  • Findings suggest that pre-existing renal conditions do not preclude successful hepatitis treatment with IFN.
  • This research supports the use of IFN in a vulnerable pediatric subgroup, potentially improving long-term outcomes.
Abstract

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...